Concepedia

Author

Mitra Tewes

University of Duisburg-EssenORCID

Also Known As

C. Ostgathe, Klaus Pantel, M Tewes, M. Tewes, MITRA TEWES, Mitra Tewes, Tewes, Mitra

145

Publications

3.5K

Citations

22

H-Index

40

Concepts

All Affiliations

University of Duisburg-EssenEssen University HospitalQiagen (Germany)Deutschen Konsortium für Translationale KrebsforschungMarienhospital Bottrop
MT

About

Mitra Tewes is an author at University of Duisburg-Essen specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

562

2

Cell Biology

2

2

215

3

Health Sciences

1

1

19

4

Nursing

1

1

22

5

Biostatistics

1

1

27

Mitra Tewes

×

33

Publications

3.1K

Citations

21

H-Index

YearCitations

Phase I Clinical and Pharmacokinetic Study of the Novel Raf Kinase and Vascular Endothelial Growth Factor Receptor Inhibitor BAY 43-9006 in Patients With Advanced Refractory Solid Tumors

Dirk Strumberg, Heike Richly, Ralf A. Hilger,

Journal of Clinical Oncology

2004

870

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

Bahriye Aktas, Mitra Tewes, Tanja Fehm,

Breast Cancer Research

2009

729

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo,

Journal of Clinical Oncology

2003

259

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

Mitra Tewes, Bahriye Aktas, Anja Welt,

Breast Cancer Research and Treatment

2008

204

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

Bahriye Aktas, Volkmar Müller, Mitra Tewes,

Gynecologic Oncology

2011

125

Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients

J. Frikkel, Miriam Götte, Mingo Beckmann,

BMC Palliative Care

2020

114

COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients

Venja Musche, Alexander Bäuerle, Jasmin Steinbach,

Frontiers in Psychology

2020

102

RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients

Corinna Keup, Bahriye Aktas, Mitra Tewes,

Clinical Chemistry

2018

69

Gene Expression Signatures in Circulating Tumor Cells Correlate with Response to Therapy in Metastatic Breast Cancer

Maren Bredemeier, Philippos Edimiris, Mikael Kubista,

Clinical Chemistry

2017

58

Phase I/II study of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor in combination with FOLFIRI as first-line treatment for patients with metastatic colorectal cancer (CRC)

Tanja Trarbach, N. Schleucher, Mitra Tewes,

Journal of Clinical Oncology

2005

53

Page 1